Trial intelligence / Profile preview

Lignocaine vs Bupivacaine for Postpartum Perineal Pain

NCT06568289Recruiting

Sponsor
Ain Shams University
Start
Mar 2024
Primary completion
Sep 2024
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of bupivacaine in postpartum perineal pain (2 arms), sponsored by Ain Shams University. Primary endpoint: Degree of pain. Started Mar 2024; status: recruiting.

02

Drugs

bupivacaine
03

Conditions

postpartum perineal pain

Beyond the preview

Go deeper on NCT06568289.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06568289.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call